. "The targeting agent directs the construct to the target tissue, preferably the tumor environment, and the attached PE-binding peptide, preferably duramycin, exerts a therapeutic effect upon delivery. [0856] Suitable targeting agents are components, such as antibodies and other agents, which bind to a tumor cell." . . .